January 17, 2017
Article
POLICY
Value-based payment improved fidelity to key elements of the Collaborative Care Model—an evidence-based mental health intervention—and improved patient depression outcomes in Washington state.
January 17, 2017
Article
COMMENTARY
For cost-effective cures, the drug pricing policy challenge is not simply to lower prices, but also to spread the drug costs among payers.
January 17, 2017
Article
CLINICAL
This study measured breast cancer screening practice patterns in relation to evidence-based guidelines and accountability metrics, and found closer alignment is needed for providing patient-centered care.
January 17, 2017
Article
WEB EXCLUSIVE
Concerns regarding the quality measure for attention-deficit/hyperactivity disorder may limit its usefulness and its ability to promote improvement efforts.
January 17, 2017
Article
METHODS
A novel, simplified cost-value analysis tool was created to better differentiate the value of anticancer agents and further characterize the expected survival benefit of all patients.
January 16, 2017
Article
WEB EXCLUSIVE
Using the most recently available national data, physicians with electronic health record (EHR) access ordered more tests than their non-EHR counterparts, thus contradicting a common rationale for EHR implementation.
January 16, 2017
Article
WEB EXCLUSIVE
This study measured the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes.
January 16, 2017
Article
WEB EXCLUSIVE
Although concerns remain that expanding insurance coverage may have a “crowding-out” effect, we saw no evidence of this for Medicaid beneficiaries in Massachusetts following statewide health reform.
December 21, 2016
Article
WEB EXCLUSIVE
Understanding the perspectives of clinicians and administrators who are leaders in implementing patient-centeredness in accountable care organizations can help point the way toward implementation by others.
December 05, 2016
Article
POLICY
Vaccination of children born in the United States in 2009 will save 1.2 million quality-adjusted life-years, generating $184 billion in social value net of vaccination costs.